Pharmaceutical Associates, Inc. appoints Dr. Suketu Sanghvi as Chief Scientific Officer

Pharmaceutical Associates, Inc. (PAI) announced today the appointment of Dr. Suketu Sanghvi as Chief Scientific Officer. Dr. Sanghvi brings significant R&D experience to PAI with over 30 years in the pharmaceutical industry which have resulted in the development and launch of over 100 generic products, a dozen branded and specialty products, and numerous ANDA first-to-file […]

Pharmaceutical Associates Inc. Names Business Development Strategist Brandon Rockwell as Chief Operating Officer

Pharmaceutical Associates, Inc. (PAI) today announced the appointment of Brandon Rockwell as Chief Operating Officer, bringing 15 years of business development experience to the company. In his new role, Rockwell will oversee PAI’s growth strategy, further solidifying the company’s position as the number one manufacturer of quality liquid pharmaceuticals in the US. Rockwell has led […]

Pharmaceutical Associates, Inc. Names Industry Leader Domenic Ciarico as Chief Commercial Officer

Pharmaceutical Associates, Inc. (PAI) today announced the appointment of Domenic Ciarico as Chief Commercial Officer, bringing with him 25 years of industry experience to the company. In his new role, Ciarico will oversee PAI’s growth strategy, further solidifying the company’s position as the number one manufacturer of quality liquid pharmaceuticals in the United States. Ciarico, […]

PAI and Intalere extend their partnership

Greenville, SC, November 1, 2020 – Pharmaceutical Associates, Inc. (PAI) today announced that the company has renewed its contract with Intalere. This renewed partnership means that Intalere members will continue to have access to the PAI portfolio of products. PAI’s products include a full line of generic liquid medicines, in a variety of bottles and […]

Enhanced Healthcare Partners and Bourne Partners Strategic Capital Announce Investment in Pharmaceutical Associates, Inc.

Backing will propel PAI’s market leadership position and help capitalize on growth opportunities NEW YORK, NY (Nov. 6, 2019) — Enhanced Healthcare Partners (“EHP”), a leading New York-based private equity firm focused on investing in middle-market healthcare businesses, together with Bourne Partners Strategic Capital (“BPSC”), a pharma services and consumer healthcare-focused investment firm, announced the […]